Why did you decide to participate in the Biomapas Academy?
The first time I heard about Biomapas Academy was from a friend who was already working in the pharmacy field. She sent me an advertisement for Biomapas Academy, which highly intrigued me. As I was in my last year of life science master studies, I wanted to discover my potential career possibilities and learn more about clinical trials. Therefore, without long thinking, I filled in the application form. I was very happy to be selected from quite many applicants and be invited to attend Biomapas Academy.
How was your experience during the three months?
We had four months of weekly lectures on different topics. They were related to the organization of clinical trials, regulatory affairs and pharmacovigilance of various medical products. Biomapas experts who resented the lectures even shared their personal experience and actual practical examples with us. We have been able to get acquainted with Biomapas company and its work specifics. Here we could expand our knowledge of the pharmaceutical industry.
How do you feel after graduating from the Academy?
I feel thrilled for taking a chance to participate in this unique project. After graduating from all the courses and tasks, I was absolutely honoured to be selected as the best student of Biomapas Academy 2020 and receive a scholarship. However, I mostly appreciate the valuable knowledge and experience I believe will be helpful for my future career. I think Biomapas Academy definitely contributes to the education of young professionals and is very useful, especially for those who want to get to know their professional opportunities better.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Case Study: Specialised Rescue Studies in Georgia
Discover how we successfully supported late‑phase clinical trials in Georgia by overcoming operational constraints, accelerating study start‑up, and restoring delivery confidence in complex research environments. This case study highlights three real‑world success...
Comprehensive Guide to Medical Information and Pharmacovigilance Integration
Discover how integrated Medical Information and Pharmacovigilance workflows enhance compliance, improve safety, and streamline regulatory processes.
Biomapas Insights: From Hope to Global Impact – How Elpida Accelerated Gene Therapy for Rare Diseases
In this Biomapas Insights episode, Martijn van de Leur, Chief Commercial Officer, speaks with Terry Pirovolakis, CEO of Elpida Therapeutics, the organisation that grew out of the CureSPG50 advocacy movement. Together, they explore how a parent-led mission to help...
Biomapas Insights: Selecting the Right CRO at the right time – What Biotechs Need to Know
Expert insights on timing, selection criteria, and early-phase clinical trial strategy for choosing the right CRO in biotech development.
Running Pan‑European Multi‑Regional Trials with Flexible FSP Models
Discover how flexible FSP models help sponsors run multi-country clinical trials across Europe with greater control, speed, and regional alignment.
Choosing the Right QPPV Partner for EU and Global Compliance
Explore the essential functions of a QPPV and discover how to choose the right partner for pharmacovigilance.
How to achieve Multi-Region Pharmacovigilance Compliance: Critical Lessons from CIS and MENA
Explore the challenges of multi-region pharmacovigilance and learn strategies for compliance in CIS and MENA markets.
Enhancing Patient Recruitment in Niche Markets Through Clinical Trial Outsourcing
Explore clinical trial outsourcing and its role in overcoming recruitment challenges in clinical research for small biotech companies.
The use of AI/Automation in Pharmacovigilance: Ensuring Safety through Robust Processes
Discover how AI and automation are transforming pharmacovigilance, including Veeva’s signal management solutions, the role of NLP and machine learning in safety workflows, and future trends in AI.
Signal Detection: An Integrated Approach to Pharmacovigilance & Regulatory Compliance
Discover how efficient signal detection manages safety risks, ensuring compliance with global regulations.















